Aboureihan Pharmaceutical

Aboureihan Pharmaceutical is a prominent Iranian pharmaceutical manufacturer established in 1965, originally as a subsidiary of the German firm Schering AG. The company is a recognized leader in the production of hormonal medications, including oral contraceptives, injectables, and topical treatments. It maintains high-standard manufacturing facilities in Tehran that produce a diverse portfolio of over 200 products across various therapeutic areas such as endocrinology, gynecology, and dermatology. As a subsidiary of Tamin Pharmaceutical Investment Company (TPICO), Aboureihan plays a critical role in the Iranian healthcare system and exports its products to several regional markets. The company is publicly traded on the Tehran Stock Exchange and is distinguished by its specialized expertise in complex hormonal formulations and sterile manufacturing.